JP Morgan Private Wealth Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,643	Closed	-$395K	–	1379
2016 Q4	$395K	Sell	3,643 -609	-14%	-$72.5K	﹤0.01%	891
2016 Q3	$700K	Sell	4,252 -333	-7%	-$52.5K	0.01%	676
2016 Q2	$654K	Buy	+4,585	New	+$669K	0.01%	697
2015 Q3	–	Sell	-2,648	Closed	-$638K	–	1159
2015 Q2	$638K	Sell	2,648 -580	-18%	-$154K	0.01%	609
2015 Q1	$910K	Buy	+3,228	New	+$699K	0.01%	549

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ICPT Position: Q1 2017 in Review

JP Morgan Private Wealth Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2017, closing a stake of 3,643 shares — an estimated $395K sold.

JP Morgan Private Wealth Advisors first reported a position in ICPT in Q1 2015 and held it in 5 quarters. The position peaked at $910K in Q1 2015. 150 funds tracked by Wall St. Rank hold ICPT as of Q1 2017.

JP Morgan Private Wealth Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 3,643 Intercept Pharmaceuticals, Inc. shares in Q1 2017, an estimated $395K.
JP Morgan Private Wealth Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
JP Morgan Private Wealth Advisors's Intercept Pharmaceuticals, Inc. position peaked at $910K in Q1 2015.
150 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2017.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2017, filed 15 May 2017.